National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 11) (No. PB 95 of 2014) (Cth)

PB 95 of 2014

National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 11)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated                  25       November 2014

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 11).

(2)   This Determination may also be cited as PB 95 of 2014.

1. Commencement

This Determination commences on 1 December 2014.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Adapalene with benzoyl peroxide

Omit

Adefovir

[2]     Schedule 1, after item dealing with Botulinum toxin type A purified neurotoxin complex

Insert

Brentuximab vedotin

[3]     Schedule 1, after item dealing with Cefuroxime

Omit

Celecoxib

[4]     Schedule 1, after item dealing with Dutasteride

Insert

Eculizumab

[5]     Schedule 1, after item dealing with Entecavir

Insert

Enzalutamide

[6]     Schedule 1, after item dealing with Glycerol

Insert

Glycine with carbohydrate

[7]     Schedule 1, after item dealing with Ivabradine

Insert

Ivacaftor

[8]     Schedule 1, after item dealing with Miconazole

Insert

Midazolam

[9]     Schedule 1, after item dealing with Oxprenolol

Omit

Oxycodone

[10]   Schedule 1, after item dealing with Quinagolide

Omit

Raloxifene

[11]   Schedule 1, after item dealing with Silver Sulfadiazine

Insert

Simeprevir

[12]   Schedule 1, after item dealing with Tyrosine with carbohydrate

Insert

Umeclidinium

[13]   Schedule 2, after item dealing with Acitretin

Insert

Adefovir

[14]   Schedule 2, after item dealing with Ceftriaxone

Insert

Celecoxib

[15]   Schedule 2, after item dealing with Diphenoxylate with atropine

Insert

Dipyridamole with Aspirin

[16]   Schedule 2, after item dealing with Donepezil

Insert

Dorzolamide with timolol

[17]   Schedule 2, after item dealing with Oxybutynin

Insert

Oxycodone

[18]   Schedule 2, after item dealing with Rabeprazole

Insert

Raloxifene

[18]   Schedule 2, after item dealing with Valsartan

Insert

Valsartan with hydrochlorothiazide